Table 2.
Analysis of the microbiological flora isolated from the upper respiratory tract (nose and pharynx) before the vaccination planned (0m) and 1–2 months after vaccination (Im).
| The group A (n = 20/100%) | The group B (n = 20/100%) | The group C (n = 10/100%) | ||||
|---|---|---|---|---|---|---|
| The nose | ||||||
| The species | 0m | Im | 0m | Im | 0m | Im |
| S. aureus | 3/15% | 1/5% | 4/20% | 4/20% | 1/10% | 1/10% |
| E. coli | 1/5% | — | — | — | — | — |
| S. marcescens | 1/5% | — | — | — | — | — |
| E. cloacae | — | — | — | — | 1/10% | — |
| Sum | 5/25% | 1/5% | 4/20% | 4/20% | 2/20% | 1/10% |
|
| ||||||
| The pharynx | ||||||
| S. aureus | 3/15% | 2/10% | 4/20% | 2/10% | 2/20% | — |
| S. pneumoniae | 1/5% | 1/5% | 2/10% | |||
| S. pyogenes | 3/15% | — | 1/5% | — | — | 1/10% |
| S. agalactiae | 1/5% | — | — | — | — | — |
| S. constellatus | — | — | 1/5% | — | — | — |
| Enterococcus spp. | 3/15% | — | 2/10% | — | — | — |
| S. marcescens | 1/5% | — | — | — | — | |
| S. odorifera | — | — | 1/5% | — | — | — |
| P. aeruginosa | 1/5% | — | — | — | — | — |
| A. hydrophila | 1/5% | — | — | — | — | — |
| C. albicans | 1/5% | 1/5% | 2/10% | 2/10% | 1/10% | — |
| C. glabrata | — | — | 1/5% | — | — | — |
| Sum | 15/75% | 4/20% | 14/70% | 4/20% | 3/30% | 1/10% |